BioSpace News Archive

Press Releases

Pediatric Neurology Organizations Partner, Receive Funding to Build Registry for Neonatal Hypoxic Ischemic Encephalopathy

October 31, 2024
·
3 min read
Press Releases

Codexis Reports Third Quarter 2024 Financial Results

October 31, 2024
·
14 min read
Press Releases

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

October 31, 2024
·
1 min read
Press Releases

Eisai Completes Rolling Submission to US FDA for LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status

October 31, 2024
·
19 min read
Press Releases

Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Multiple Sclerosis

October 31, 2024
·
2 min read
Press Releases

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

October 31, 2024
·
5 min read
Press Releases

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

October 31, 2024
·
8 min read
Press Releases

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

October 31, 2024
·
13 min read
Press Releases

Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024

October 31, 2024
·
1 min read
Press Releases

NewBiologix Launches Xcell™ to Accelerate, Optimize, and Scale Gene and Cell Therapy Production

October 31, 2024
·
2 min read